Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.

Current atherosclerosis reports - 1 May 2009

Rosenson Robert S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-V
Share to Apolipoproteins A
Share to Cholesterol, HDL
Share to Hypolipidemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipoproteins

Share to Pharmacogenetics

Share to Postprandial Period

Share to Triglycerides

Source

Identifiers

PMID: 19361346
DOI: 10.1007/s11883-009-0026-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.PMID 19361346Read ↗

Fibrate pharmacogenomics: expanding past the genome.Semantic proximity Read ↗

National Lipid Association Annual Summary of Clinical Lipidology 2015.Semantic proximity Read ↗

Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.Semantic proximity Read ↗

Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.Semantic proximity Read ↗

Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysisSemantic proximity Read ↗

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Semantic proximity Read ↗

Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.Semantic proximity Read ↗

A new dawn for managing dyslipidemias: The era of rna-based therapiesSemantic proximity Read ↗

Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study.Semantic proximity Read ↗

Pharmacogenomics of blood lipid regulation.Semantic proximity Read ↗

Very Large Database of Lipids: Rationale and DesignSemantic proximity Read ↗

Nutritional-Metabolic Lipid Profiling with LipidOne for plasma lipidomics interpretation in metabolic healthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.